Brief: VVT Med Establishes Exclusive Canadian Commercial Partnership With Chs For Sclerosafe®
01/10/2026 22:13
BRIEF-VVT Med Establishes Exclusive Canadian Commercial Partnership With Chs For Sclerosafe® Oct 1 (Reuters) - VVT Med Inc VVTM.V:
VVT MED ESTABLISHES EXCLUSIVE CANADIAN COMMERCIAL PARTNERSHIP WITH CHS FOR SCLEROSAFE®
VVT MED - AGREEMENT EFFECTIVE UPON HEALTH CANADA AUTHORIZATION WITH INITIAL TERM OF FIVE YEARS
VVT MED: INTENDS TO PURSUE APPLICABLE REGULATORY PROCESS REQUIRED TO SUPPORT COMMERCIAL INTRODUCTION IN CANADA
Source text: ID:nCNWQjW3Za
Further company coverage: VVTM.V
((((Reuters.Briefs@thomsonreuters.com;));))
Recent news on VVT Med
See all newsBrief: VVT Med Establishes Exclusive Canadian Commercial Partnership With Chs For Sclerosafe®
Brief: VVT Med Closes Second Tranche Of Private Placement Of Units Over $1.8M In Total Proceeds Raised
Brief: Vvt Med Expands European Commercial Footprint Through Exclusive Distribution Agreement In Greece
Brief: VVT Med Provides Update On Management Cease Trade Order
Brief: VVT Med Receives Order From Major Us Healthcare Network Northwell Health And Enters Into Investor Relations Agreements